Aleksandra Wierzbowski, Robert Pless, K. Hildebrand
{"title":"NACI关于成人肺炎球菌疫苗使用的公共卫生建议的声明摘要,包括使用15价和20价结合疫苗","authors":"Aleksandra Wierzbowski, Robert Pless, K. Hildebrand","doi":"10.14745/ccdr.v49i23a08f","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Résumé de la déclaration du CCNI sur les recommandations au niveau de la santé publique sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent\",\"authors\":\"Aleksandra Wierzbowski, Robert Pless, K. Hildebrand\",\"doi\":\"10.14745/ccdr.v49i23a08f\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":33496,\"journal\":{\"name\":\"Canada Communicable Disease Report\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canada Communicable Disease Report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14745/ccdr.v49i23a08f\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada Communicable Disease Report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/ccdr.v49i23a08f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Résumé de la déclaration du CCNI sur les recommandations au niveau de la santé publique sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent